NEONATAL JAUNDICE AND MOLECULAR MUTATIONS IN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT NEWBORN-INFANTS

Citation
Cs. Huang et al., NEONATAL JAUNDICE AND MOLECULAR MUTATIONS IN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT NEWBORN-INFANTS, American journal of hematology, 51(1), 1996, pp. 19-25
Citations number
31
Categorie Soggetti
Hematology
ISSN journal
03618609
Volume
51
Issue
1
Year of publication
1996
Pages
19 - 25
Database
ISI
SICI code
0361-8609(1996)51:1<19:NJAMMI>2.0.ZU;2-L
Abstract
Molecular mutations of the glucose-6-phosphate dehydrogenase (GGPD) ge ne and clinical manifestations of neonatal jaundice in 112 male and 50 female Chinese neonates with G6PD deficiency were studied, In the 112 males, the nucleotide (nt) 1376 (G-->T) mutation was the dominant typ e (50.0%), followed by nt 1388 (G-->A) (16.1%), nt 493 (A-->G) (8.0%), nt 1024 (C-->T) (6.2%), nt 95 (A-->G) (5.4%), nt 392 (G-->T) (1.8%), nt 487 (G-->A) (1.8%), nt 871 (G-->A) (0.9%), and nt 1360 (C-->T) (0.9 %). The nt 871 variant has not been reported in Taiwan before, The occ urrence rates for nt 1376, nt 1388, nt 493, nt 95, and nt 1024 mutatio ns in the 50 females were 44.0%, 18.0%, 12.0%, 6.0%, and 6.0%, respect ively, The type of G6PD mutation in 10 male and 7 female neonates has not been identified yet. Although G6PD deficient neonates had higher f requency of phototherapy than G6PD normal neonates in both sexes, a si gnificant difference in the prevalence of hyperbilirubinemia (peak bil irubin greater than or equal to 15.0 mg/dl) between G6PD deficient and normal neonates was found only in males, Further analysis showed that duration of phototherapy was longer in G6PD deficient male neonates t han in the control group, while the outcome of phototherapy was better in subjects with non-nt 1376 mutations than subjects with the nt 1376 mutation, Most (78.3%) of the 23 G6PD deficient neonates who subseque ntly suffered from neonatal hyperbilirubinemia carried the nt 1376 mut ation, The results of this study indicate that the nucleotide substitu tion at 1376 is the most common and important mutation for G6PD defici ency in Chinese neonates in Taiwan. (C) 1996 Wiley-Liss, Inc.